… Since the discovery of COVID-19 in December 2019, numerous antivirals … antiviral strategies
currently employed and summarizes reported in vitro and in vivo efficacies of key antiviral …

… as a novel antiviral strategy for the treatment of COVID-19. … licensed vaccine products for
COVID-19. Under the condition … and efficacy for COVID-19 treatment, novel antiviral strategies, …

… So far, a few small-molecule antiviral … of COVID-19, mostly requiring administration within
10 days of symptom onset. In addition, hospitalized patients with severe or critical COVID-19 …

… The current COVID-19 emergency warrants the urgent development of potential strategies
… , among others—even if more robust data on antiviral therapies is yet to come. A key reason …

… treating COVID-19. However, remdesivir’s clinical effects are controversial and new antiviral
drugs … We will discuss the current status of the drug discovery efforts against COVID-19 and …

… COVID-19 management, including the virus-targeting inhibitors and host-targeting agents,
with their antiviral … future prospect of developing potent therapeutic agents against COVID-19. …

… in treating refractory CMV pneumonia, COVID-19 pneumonia should be prevented with …
antiviral therapy for COVID-19 based on clinical trials of favipiravir for the treatment of COVID-19 …

… the pathogenesis of COVID-19. Both the virus and host factors are potential targets for
antiviral therapy. Hence, in this study, the current therapeutic strategies of COVID-19 have been …

… antiviral therapy and assess their synergies. We focus here on two prominent forms of therapy
against COVID-19… that remdesivir is an effective antiviral treatment option for COVID-19 [4]. …

… highly-innovative antiviral agents to work against the viruses. We hypothesize that some of
the antiviral coatings discussed here could exert an inhibitive effect on COVID-19, indicated …